Triactiv FX Embolic Protection System, Model PN 60040-02 and 1 more
Temporary Coronary Saphenous Vein Bypass Graft For Embolic Protection. 510(k) K062870, from Kensey Nash Corp. (Exton, PA). Product code NFA, class 2.
As of Nov 20, 2026, K062870 is an FDA 510(k) held by Kensey Nash Corp., substantially equivalent on Oct 20, 2006 after 25 days, with no recalls tied to it in FDA's recall database.
- Review time: 25 days
- Recalls: 0
The TriActiv FX® Embolic Protection System is indicated for use in conjunction with percutaneous coronary intervention (PCI), using a 7F guide catheter (without side holes), of diseased saphenous vein coronary bypass grafts ranging from 3.0mm to 5.0m in diameter.
- Triactiv FX Embolic Protection SystemK061772 · Kensey Nash Corp. · Jul 11, 2006
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Sep 25, 2006
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.1250
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files